Guest Editorial SABCS: 46 years at the forefront of clinical and translational research in breast cancer—and still growing February 16, 2024Vol.50 No.07By Virginia Kaklamani, Srivani Ravoori and Carlos L. Arteaga
Clinical Roundup Novel drug combination shows promise in advanced HER2-negative breast cancer treatment February 16, 2024Vol.50 No.07
Clinical Roundup Rice study finds checkpoint inhibitor that could help treat breast cancer bone metastases February 02, 2024Vol.50 No.05
Clinical Roundup Molecular profiles of tissue plus circulating tumor DNA can better guide cancer care January 26, 2024Vol.50 No.04
Clinical Roundup Natural compounds derived from soy, plants reduce breast cancer recurrence, study shows January 12, 2024Vol.50 No.02
Clinical Roundup Inavolisib combination demonstrates 57% PFS in breast cancer indication January 05, 2024Vol.50 No.01
Clinical Roundup Kadcyla demonstrates OS benefit in breast cancer indication January 05, 2024Vol.50 No.01
In Brief Aditya Bardia to lead breast cancer program and translational research integration at UCLA Health December 15, 2023Vol.49 No.46
Clinical Roundup Kadcyla produces OS benefit in HER2+ early-stage breast cancer with residual invasive disease after neoadjuvant treatment December 15, 2023Vol.49 No.46
